Overview

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function

Status:
Active, not recruiting

Trial end date:
2034-12-10

Target enrollment:

Participant gender:

Summary

The study aims to investigate whether oral betablocker (BB) therapy is superior to no such treatment following an acute myocardial infarction (AMI).

Phase:

Phase 4

Details

Lead Sponsor:

Oslo University Hospital

Collaborators:

Diakonhjemmet Hospital
Haukeland University Hospital
Helse Stavanger HF
Lovisenberg Diakonale Hospital
Nordlandssykehuset HF
Norwegian University of Science and Technology
Ostfold Hospital Trust
Sorlandet Hospital HF
St. Olavs Hospital
Sykehuset Innlandet HF
The Hospital of Vestfold
University Hospital of North Norway
University of Oslo
Vestre Viken Hospital Trust

Treatments:

Adrenergic beta-Antagonists